Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma
Chiu, Hsiling, Trisal, Preeti, Bjorklund, Chad, Carrancio, Soraya, Toraño, Estela G., Guarinos, Carla, Papazoglou, Despoina, Hagner, Patrick R., Beldi-Ferchiou, Asma, Tarte, Karin, Delfau-Larue, MarieLanguage:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.15797
Date:
February, 2019
File:
PDF, 872 KB
english, 2019